Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Colombo Fort Land & Building Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Colombo Fort Land & Building şirketinin toplam hissedar öz sermayesi LKR12.6B ve toplam borcu LKR32.1B olup, bu da borç-öz sermaye oranını 254.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla LKR69.0B ve LKR56.4B dir. Colombo Fort Land & Building 'in FAVÖK'ü LKR3.8B faiz karşılama oranı 0.9 dur. Şirketin LKR4.2B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

254.3%

Borç/özkaynak oranı

LK₨32.05b

Borç

Faiz karşılama oranı	0.9x
Nakit	LK₨4.25b
Eşitlik	LK₨12.60b
Toplam yükümlülükler	LK₨56.42b
Toplam varlıklar	LK₨69.02b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CFLB.N0000 'nin kısa vadeli varlıkları ( LKR31.6B ) kısa vadeli yükümlülüklerini ( LKR35.7B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: CFLB.N0000 şirketinin kısa vadeli varlıkları ( LKR31.6B ) uzun vadeli yükümlülüklerini ( LKR20.7B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CFLB.N0000 'nin net borç/öz sermaye oranı ( 220.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CFLB.N0000 şirketinin borç/öz sermaye oranı son 5 yılda 221.5% seviyesinden 254.3% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: CFLB.N0000 şirketinin mevcut serbest nakit akışına dayanarak yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Tahmini Nakit Akışı: CFLB.N0000 tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Colombo Fort Land & Building Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: LK₨0.05 loss per share (vs LK₨0.46 profit in 1Q 2024)

Group MD & Executive Director recently bought LK₨89k worth of stock

New minor risk - Share price stability

Group MD & Executive Director recently bought LK₨102k worth of stock

Full year 2024 earnings released: LK₨0.56 loss per share (vs LK₨9.78 profit in FY 2023)

Group MD & Executive Director recently bought LK₨391k worth of stock

Group MD & Executive Director recently bought LK₨310k worth of stock

Group MD & Executive Director recently bought LK₨456k worth of stock

Group MD & Executive Director recently bought LK₨277k worth of stock

Third quarter 2024 earnings released: LK₨0.95 loss per share (vs LK₨2.03 profit in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.85 loss per share (vs LK₨6.87 profit in 2Q 2023)

Group MD & Executive Director recently sold LK₨4.2m worth of stock

New minor risk - Share price stability

Upcoming dividend of LK₨0.25 per share at 0.8% yield

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC Proposes First and Final Dividend

The Colombo Fort Land & Building PLC, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: LK₨0.46 (vs LK₨1.55 in 1Q 2023)

Full year 2023 earnings released: EPS: LK₨12.43 (vs LK₨1.48 loss in FY 2022)

Non-Executive Director recently bought LK₨5.7m worth of stock

Third quarter 2023 earnings released: EPS: LK₨2.03 (vs LK₨1.51 in 3Q 2022)

Investor sentiment improves as stock rises 15%

The Colombo Fort Land & Building plc Announces Demise of Ranjeevan Seevaratnam, Independent Non-Executive Director

Second quarter 2023 earnings released: EPS: LK₨6.87 (vs LK₨0.30 in 2Q 2022)

Less than half of directors are independent

Non-Executive Director recently bought LK₨2.1m worth of stock

Non-Executive Director recently bought LK₨3.5m worth of stock

Independent Non Executive Director recently bought LK₨2.6m worth of stock

Independent Non Executive Director recently bought LK₨1.7m worth of stock

First quarter 2023 earnings released: EPS: LK₨1.55 (vs LK₨0.39 in 1Q 2022)

Full year 2022 earnings released: LK₨1.50 loss per share (vs LK₨2.35 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Group MD & Executive Director recently bought LK₨1.4m worth of stock

Group MD & Executive Director recently bought LK₨1.0m worth of stock

Non-Executive Director recently bought LK₨22m worth of stock

Group MD & Executive Director recently bought LK₨206k worth of stock

Second quarter 2022 earnings released: LK₨0.30 loss per share (vs LK₨0.30 loss in 2Q 2021)

First quarter 2022 earnings released: EPS LK₨0.39 (vs LK₨0.51 loss in 1Q 2021)

Group MD & Executive Director recently bought LK₨148k worth of stock

Third quarter 2021 earnings released: EPS LK₨1.11 (vs LK₨1.85 loss in 3Q 2020)

Group MD & Executive Director recently bought LK₨1.2m worth of stock

New 90-day high: LK₨13.40

Second quarter 2021 earnings released: LK₨0.30 loss per share

Group MD & Executive Director recently sold LK₨711k worth of stock

Non-Executive Chairman recently sold LK₨3.8m worth of stock

New 90-day high: LK₨13.30

First quarter earnings released

Full year earnings released - LK₨8.89 loss per share

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin